Literature DB >> 25893488

Profiling psychotropic discharge medication from a children's psychiatric ward.

Gazala Akram1.   

Abstract

Background Community prescribing of medication to treat psychiatric illness in children is increasing. However, details about medication prescribed at discharge from psychiatric inpatient services for children are scarce. Objectives Characterise the nature of psychotropic medication prescribed on discharge from a children's psychiatric ward over a 15-year period. Method Retrospective analysis of discharge summary letters of all discharges occurring between Jan 1997 to Dec 2012. Results 234 children (152 males and 82 females) were discharged with 117 (50%) prescribed psychotropic medication at discharge. 133 medicines were prescribed (stimulants n = 49, antipsychotics n = 31, antidepressants n = 22, mood stabilisers n = 1, other ADHD medication n = 11, melatonin n = 10, benzodiazepines n = 7, other n = 2). Risperidone was the most popular antipsychotic at a mean daily dose of 1 mg (range 0.25-4 mg). Fifty per cent were given an unlicensed medicine or a licensed drug was used in an unlicensed manner, of which risperidone was the most common (n = 14). Sleep disturbance and tics were most often treated using unlicensed/off label medication (n = 10). Conclusion Psychotropic medication is routinely used in inpatient children's services, with the majority of use confined to stimulants and atypical antipsychotics. Much of the antipsychotic use is for unlicensed indications or at unlicensed doses.

Entities:  

Keywords:  Antipsychotics; Child psychiatry; Psychotropic medication; United Kingdom; Unlicensed indications

Mesh:

Substances:

Year:  2015        PMID: 25893488     DOI: 10.1007/s11096-015-0116-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  5 in total

Review 1.  Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.

Authors:  Christoph U Correll
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

Review 2.  Cognitive behavioural therapy for anxiety disorders in children and adolescents.

Authors:  A James; A Soler; R Weatherall
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

3.  Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.

Authors:  Michael H Bloch; Kaitlyn E Panza; Angeli Landeros-Weisenberger; James F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-09       Impact factor: 8.829

4.  Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK.

Authors:  Yingfen Hsia; Karyn Maclennan
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

Review 5.  Physical health monitoring of patients with schizophrenia.

Authors:  Stephen R Marder; Susan M Essock; Alexander L Miller; Robert W Buchanan; Daniel E Casey; John M Davis; John M Kane; Jeffrey A Lieberman; Nina R Schooler; Nancy Covell; Scott Stroup; Ellen M Weissman; Donna A Wirshing; Catherine S Hall; Leonard Pogach; Xavier Pi-Sunyer; J Thomas Bigger; Alan Friedman; David Kleinberg; Steven J Yevich; Bonnie Davis; Steven Shon
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

  5 in total
  1 in total

1.  Psychotropic drugs for the treatment of non-suicidal self-injury in children and adolescents: a systematic review and meta-analysis.

Authors:  Vincent Eggart; Sebastian Cordier; Alkomiet Hasan; Elias Wagner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-02-16       Impact factor: 5.270

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.